An interventional study of Blood pressure and Positive end expiratory pressure in Patients Undergoing General Anesthesia, sponsored by Lars Wiuff Andersen. Completed at 6 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-05.
Sponsored by Lars Wiuff Andersen · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This trial is an investigator-initiated, multicenter, randomized, factorial, single-blind trial of multiple hemodynamic and respiratory targets during general anesthesia. These targets include blood pressure, positive end expiratory pressure, tidal volume, and fraction of inspired oxygen. Patients will be randomized to different targets using a factorial design, i.e., each patient is simultaneously randomized to four interventions. There will be five enrolling sites in the Central Denmark Region. 480 high-risk patients will be enrolled.
Lars Wiuff Andersen is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Blood pressure
Procedure: Blood pressure
Procedure: Blood pressure
Procedure: Blood pressure
Procedure: Positive end expiratory pressure
Procedure: Positive end expiratory pressure
Procedure: Positive end expiratory pressure
Procedure: Tidal volume
Procedure: Tidal volume
Procedure: Tidal volume
Procedure: Fraction of inspired oxygen
Procedure: Fraction of inspired oxygen
Blood pressure targets during general anesthesia and 2 hours after
Positive end expiratory pressure during general anesthesia
Tidal volume during general anesthesia
Fraction of inspired oxygen during general anesthesia and 2 hours after
Feasibility: Proportion of eligible patients randomized
Eligible patients will be defined as those meeting all inclusion criteria and none of the exclusion criteria 1 to 4.
Time frame: Up to 90 days
Feasibility: Proportion of patient with adherence to the assigned interventions
Adherence will be defined as follows: The allocated positive end expiratory pressure (± 1 cm H2O), tidal volume (± 1 ml/kg), and FiO2 (± 5%) is used in a minimum of 90% of the randomized patients for the duration of the surgery. Vasopressors/inotropes are only initiated and continued if the blood pressure declines below the allocated target in at least 60% of the patients and at least 60% of time during general anesthesia, i.e., 60% of the registered blood pressures should be within +/- 10 mmHg of the target when vasopressor/inotropes are administered.
Time frame: During surgery
Feasibility: Proportion of patients with separation of mean arterial pressure
We aim to achieve at least 5 mmHg separation in mean/median mean arterial pressure for the three blood pressure groups targeting mean arterial pressure.
Time frame: During surgery
Feasibility: Proportion of patients lost to follow-up
We aim to obtain data from more than 90% of patients still alive at 30- and 90-days follow-up.
Time frame: Up to 90 days
Proportion of patients with pulmonary post-operative complications (composite)
A composite of the following based on European Perioperative Clinical Outcome definitions: Respirator infection, respirator failure, pleural effusion, atelectasis, pneumothorax, bronchospasms, and aspiration pneumonitis.
Time frame: 30 days
Proportion of patient with pneumonia
Based on the United States of America Centers for Disease Control and Prevention (CDC) definition of pneumonia
Time frame: 30 days
Proportion of patient with pulmonary embolism
Presence of pulmonary embolus on computerized tomography (CT) or magnetic resonance (MR) imaging, or a high probability of pulmonary embolus based on ventilation perfusion scan.
Time frame: 30 days
Proportion of patient with acute kidney injury
Composite of post-operative renal complications using Kidney Disease Improving Global Outcomes (KDIGO) criteria
Time frame: 30 days
Creatinine
Measured in umol/L
Time frame: 2 hours after the surgery
Creatinine
Measured in umol/L
Time frame: The day after the surgery
Proportion of patient with major adverse cardiac events
A composite of the following based on European Perioperative Clinical Outcome definitions: Non-fatal cardiac arrest, acute myocardial infarction, congestive heart failure, new cardiac arrhythmia, and angina.
Time frame: 30 days
Troponin-I
Measured in ng/L
Time frame: 2 hours after the surgery
Troponin-I
Measured in ng/L
Time frame: The day after the surgery
Proportion of patients with myocardial injury after non-cardiac surgery
Post-operative troponin-I above the 99% percentile for the respective assay.
Time frame: 3 days
Alanine transaminase
Measured in U/L
Time frame: 2 hours after the surgery
Alanine transaminase
Measured in U/L
Time frame: The day after the surgery
Proportion of patients with emergence delirium
Based on the nursing delirium screening scale to evaluate emergence delirium 90-120 minutes after admission to the post-aesthesia care unit.
Time frame: 2 hours after the surgery
Proportion of patients with post-operative delirium
We will categorize delirium as delirium if this is either stated in the medical journal or retrospectively categorized as delirium if it meets pre-defined criteria based on the diagnostic and statistical manual of mental disorders, fifth edition from the American psychiatric association
Time frame: 7 days
Post-operative pain
Highest numeric rating scale (NRS) score (from 0 to 10 with higher scores indicating worse pain) documented
Time frame: 2 hours after the surgery
Opioid administered
Total opioid administered using morphine equivalent units.
Time frame: 24 hours
Proportion of patients with post-operative nausea and vomiting
Highest numeric rating scale (NRS) score (from 0 to 10 with higher scores indicating worse nausea and vomiting) documented
Time frame: 2 hours after the surgery
Antiemetic treatment
Administered antiemetic treatment (ondansetron, dexamethasone, cyclizine, droperidol, metoclopramide) within the first 24 hours after the operation.
Time frame: 24 hours
Proportion of patients with surgical site infections
Based on the United States of America Centers for Disease Control and Prevention (CDC) definition.
Time frame: 30 days
Clavien-Dindo grading of complications
In addition to reporting the individual post-operative complications, we will use the validated Clavien-Dindo classification to grade post-operative complications by the interventions needed.
Time frame: 30 days
Proportion of patients with intensive care unit admission
Both planned and unplanned stays at the intensive care unit.
Time frame: 30 days
Length of hospital stay
Reported in days.
Time frame: Up to 90 days
Days alive and out of the hospital
Reported in days. Patients that die during the 30 days, will receive a value of 0. All admissions at acute care hospitals in Denmark will be included in this outcome.
Time frame: Within 30 days
Proportion of patients with who die
Time frame: 30 days
Proportion of patients with who die
Time frame: 90 days
Health related quality of life
Based on the EQ-5D-5L questionnaire
Time frame: 30 days
Health related quality of life
Based on the EQ-5D-5L questionnaire
Time frame: 90 days
Proportion of patients with intraoperative complications
Specific complications occurring during the surgery: Bleeding, need of blood product transfusions, arrhythmia, pneumothorax, cardiac arrest, mortality.
Time frame: During surgery
Quality of recovery
Based on the quality of recovery-15 (QoR-15) score. The score ranges from 0-150 with higher scores indicating better recovery.
Time frame: 30 days
Quality of recovery
Based on the quality of recovery-15 (QoR-15) score. The score ranges from 0-150 with higher scores indicating better recovery.
Time frame: 90 days
Plan to share: Yes — Six months after the publication of the last results, all de-identified individual patient data will be made available for data sharing. Procedures, including re-coding of key variables, will be put in place to allow for complete de-identification of the data. Data will be completely anonymized according to Danish law. All relevant trial-related documents, including the protocol, data dictionary, and the main statistical code, will be shared along with the data. There will be no predetermined end date for the data sharing.
Supporting information: Study protocol
Access criteria: Data will be available for any research purpose to all interested parties who have approval from an independent review committee and who have a methodological sound proposal as determined by the steering committee of the current trial. Only the methodological qualities and not the purpose or objective of the proposal will be considered. Interested parties will be able to request the data by contacting the principal investigator. Authorship of publications emerging from the shared data will follow standard authorship guidelines from the International Committee of Medical Journal Editors and might or might not include authors from the steering committee depending on the nature of their involvement.
Ran from Oct 2023 to primary completion in Apr 2025, 18 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lars Wiuff Andersen